Among the included Chinese patients being treated for T2DM, metformin and acarbose mainly exerted different interactive effects with dietary energy, carbohydrate, and protein intakes on GLP-1 secretion, insulin release, and SBP. This evidence concerns the gene INS and type 2 diabetes mellitus.